Navigation Links
Ampio Pharmaceuticals announces the opening of its new headquarters, manufacturing and research facility in Englewood Colorado
Date:7/23/2014

ENGLEWOOD, Colo., July 23 2014 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced the opening of its new headquarters, manufacturing and research facility:

Ampio Pharmaceuticals,
373 Inverness Parkway
Englewood, CO 80112
Direct: (720) 437-6500

Michael Macaluso, Ampio's CEO, noted  "This advanced, labor efficient, pharmaceutical drug manufacturing facility will be fully operational this summer, right on schedule, to produce the first batches of AmpionTM necessary to accommodate the company's BLA application to treat osteoarthritis-of-the- knee (OAK). This factory is designed to manufacture and package 10 million doses per year of AmpionTM as an injectable drug for the treatment of osteoarthritis as well as for additional formulations of AmpionTM to treat other clinical indications. This factory will be fully compliant with regulatory requirements for both the USA and international medical manufacturing. Also located in this facility are State-of-the-art molecular biology and analytical research laboratories."

About Ampio Pharmaceuticals
Ampio Pharmaceuticals, Inc. is a clinical trial stage biopharmaceutical company primarily focused on the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options. We are developing compounds that decrease inflammation by (i) inhibiting specific pro-inflammatory compounds by affecting specific pathways at the protein expression and at the transcription level; (ii) activating specific phosphatase or depletion of the available phosphate needed for the inflammation process; and (iii) decreasing vascular permeability.

Forward Looking Statements
Ampio's statements in this press release that are not historical fact and that relate to future plans or events are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by use of words such as "believe," "expect," "plan," "anticipate," and similar expressions. These forward-looking statements include statements regarding Ampio's expectations with respect to the completion, timing and size of the registered direct offering, as well as risks associated with clinical trials, expected results, regulatory approvals, and changes in business conditions and similar events. The risks and uncertainties involved include those detailed from time to time in Ampio's filings with the Securities and Exchange Commission, including without limitation, under Ampio's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q.  Ampio undertakes no obligation to revise or update these forward-looking statements, whether as a result of new information, future events or otherwise. 

Investor Contact:
April Ramirez
Operations Coordinator
Ampio Pharmaceuticals, Inc.
Direct: (720) 437-6500

Logo - http://photos.prnewswire.com/prnh/20120516/MM09116LOGO


'/>"/>
SOURCE Ampio Pharmaceuticals, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Thursday, July 24
2. Champions Oncology Names Angela Davies, M.D., Chief Medical Officer
3. Ampio Pharmaceuticals to Present at Upcoming Investor Conference
4. Ampio Pharmaceuticals, Inc. States that its Policy is Not to Comment on Unusual Market Activity
5. Ampio Pharmaceuticals subsidiary Luoxis Diagnostics announces positive summary data from study of traumatic brain injury patients and issuance of companys third US patent for its oxidation-reduction potential diagnostic platform
6. Ampio Pharmaceuticals, Inc. Announces Additional Positive Results for Ampion(TM) in Osteoarthritis of the Knee Clinical Trial
7. Ampio Pharmaceuticals, Inc. Announces $25 Million Financing
8. Astellas to Host Executive Womens Day at 2013 TOUR Championship by Coca-Cola
9. Ampio Pharmaceuticals, Inc. Announces Positive Results for Ampion in Osteoarthritis of the Knee Clinical Trial
10. Levine Leichtman Acquires Champion Manufacturing
11. Pro Athletes Team Up to Champion Gout Awareness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/13/2019)... LONE TREE, Colo. (PRWEB) , ... June 13, ... ... CO, is thrilled to open its doors to a wellness center dedicated to ... A. Atagi of Atagi Plastic Surgery & Skin Aesthetics, BESANA Health & Wellness ...
(Date:6/13/2019)... ... June 13, 2019 , ... IPVideo Corporation ... visual weapons detection systems, is proud to announce its verified integration with its ... verified technology partner IPVideo’s award-winning HALO sensor is now available on the Milestone ...
(Date:6/13/2019)... ... June 13, 2019 , ... The American Psychiatric Nurses Association announced ... current executive director Nicholas Croce Jr., MS. The search will be led by an ... past APNA Presidents, and Council and Chapter leaders. , The job description and more ...
Breaking Medicine Technology:
(Date:6/12/2019)... ... June 12, 2019 , ... ... relationships with caregivers and dementia patients to deteriorate. , Researchers from the ... a survey with professional caregivers who care for people who have dementia and ...
(Date:6/12/2019)... ... ... In September of 2018, NVNA and Hospice (NVNA) partnered with Health Recovery ... its full-scale launch in March, NVNA has expanded its program with HRS to provide ... has achieved an average all-cause hospital readmissions rate of 7.3% and has seen a ...
(Date:6/12/2019)... YORK (PRWEB) , ... June 12, 2019 , ... ... disability that significantly impacts their life, preventing them from participating in education or ... Project (ICP) will urge policymakers to recognize communication as a human right and ...
(Date:6/11/2019)... ... 11, 2019 , ... CareSet announced today that co-founder Ashish Patel has been ... through the TMCx Accelerator startup program and into expanded new offices located in Uptown, ... grown into a company of 18 and climbing. , “Ashish’s passion and work ...
(Date:6/6/2019)... ... June 06, 2019 , ... Dr. Eugene A. Isola III is an ... Hackensack Meridian Raritan Bay Medical Center. For Dr. Isola, dentistry is not just a ... Isola knows the importance of providing five-star services and treats his patients as if ...
Breaking Medicine News(10 mins):